
Results
2
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
2 companies
PeptiDream
Market Cap: JP¥201.5b
A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.
4587
JP¥1,559.50
7D
-4.6%
1Y
-42.2%
Nxera Pharma
Market Cap: JP¥81.1b
Develops and sells pharmaceutical products in Japan, the United States, Germany, Switzerland, Bermuda, and the United Kingdom.
4565
JP¥896.00
7D
-7.2%
1Y
-26.1%